NU50CK000597
Cooperative Agreement
Overview
Grant Description
Improving Health Outcomes through Partnerships with Physicians to Prevent and Control Emerging and Re-emerging Infectious Disease Threats - The AMA's Code of Medical Ethics recognizes that at the national, regional, or local level, responses to disasters, including infectious disease outbreaks, require extensive involvement from physicians individually and collectively.
Because of their commitment to care for the sick and injured, individual physicians have an obligation to provide urgent medical care during pandemics. This obligation holds even in the face of greater than usual risks to physicians' own safety, health, or life.
In order to support physicians' obligation in a pandemic, the AMA has a responsibility to be a trusted source of information and education for physicians, health professionals, and the public on infectious disease outbreaks affecting the U.S. population.
The AMA's role in the COVID-19 response efforts to date has included providing up-to-date, evidence-based research, resources, and guidance from a variety of trusted sources. The American Medical Association and the JAMA Network are compiling up-to-the-moment information and research for physicians on how to prevent, diagnose, and treat COVID-19.
The AMA has created a COVID-19 Resource Center, which includes evidence-based perspectives from top researchers, AMA's physician leaders, and subject matter experts on how physicians can prepare and respond to a pandemic. The AMA is creating an interface with physicians on the front line of the epidemic and shining a light on the realities of the situation. We are listening empathically to physicians, answering their questions, sharing their experiences, and channeling their voices and feedback to other physicians, federal agencies, and health organizations.
This includes convening a health system leader roundtable to learn from front-line physician and health system leaders, holding calls with state medical societies and national medical specialty societies to identify challenges and best practices, interviewing physician leaders from front-line areas (i.e., Italy) for key learnings and guidance, conducting Facebook Live question and answer sessions with AMA physician leaders and subject matter experts, fielding physician surveys to identify the key issues and needs among physicians, speaking for physicians with key federal agencies, and showcasing the work of front-line physicians.
The AMA seeks to strengthen the nation's response to emerging and re-emerging infectious disease threats by engaging physicians and medical students in prevention and control efforts. The AMA's role in responding to COVID-19 is four-fold: (1) providing up-to-date, evidence-based research, resources, and guidance from trusted sources, (2) creating an interface with physicians on the front line of the pandemic to inform the development of tools, resources, and best practices; (3) leveraging the AMA Ed Hub and other AMA platforms to engage physicians in training and targeting guidance and tools to specific physician audiences, and (4) leveraging the Federation of Medicine, which is made up of state and national medical specialty societies, and engaging those disproportionately affected by infectious disease threats to identify and solve problems.
Because of their commitment to care for the sick and injured, individual physicians have an obligation to provide urgent medical care during pandemics. This obligation holds even in the face of greater than usual risks to physicians' own safety, health, or life.
In order to support physicians' obligation in a pandemic, the AMA has a responsibility to be a trusted source of information and education for physicians, health professionals, and the public on infectious disease outbreaks affecting the U.S. population.
The AMA's role in the COVID-19 response efforts to date has included providing up-to-date, evidence-based research, resources, and guidance from a variety of trusted sources. The American Medical Association and the JAMA Network are compiling up-to-the-moment information and research for physicians on how to prevent, diagnose, and treat COVID-19.
The AMA has created a COVID-19 Resource Center, which includes evidence-based perspectives from top researchers, AMA's physician leaders, and subject matter experts on how physicians can prepare and respond to a pandemic. The AMA is creating an interface with physicians on the front line of the epidemic and shining a light on the realities of the situation. We are listening empathically to physicians, answering their questions, sharing their experiences, and channeling their voices and feedback to other physicians, federal agencies, and health organizations.
This includes convening a health system leader roundtable to learn from front-line physician and health system leaders, holding calls with state medical societies and national medical specialty societies to identify challenges and best practices, interviewing physician leaders from front-line areas (i.e., Italy) for key learnings and guidance, conducting Facebook Live question and answer sessions with AMA physician leaders and subject matter experts, fielding physician surveys to identify the key issues and needs among physicians, speaking for physicians with key federal agencies, and showcasing the work of front-line physicians.
The AMA seeks to strengthen the nation's response to emerging and re-emerging infectious disease threats by engaging physicians and medical students in prevention and control efforts. The AMA's role in responding to COVID-19 is four-fold: (1) providing up-to-date, evidence-based research, resources, and guidance from trusted sources, (2) creating an interface with physicians on the front line of the pandemic to inform the development of tools, resources, and best practices; (3) leveraging the AMA Ed Hub and other AMA platforms to engage physicians in training and targeting guidance and tools to specific physician audiences, and (4) leveraging the Federation of Medicine, which is made up of state and national medical specialty societies, and engaging those disproportionately affected by infectious disease threats to identify and solve problems.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Place of Performance
Illinois
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 157% from $2,000,000 to $5,130,600.
American Medical Association was awarded
Physician Partnerships for Infectious Disease Control
Cooperative Agreement NU50CK000597
worth $5,130,600
from National Center for Emerging and Zoonotic Infectious Diseases in September 2021 with work to be completed primarily in Illinois United States.
The grant
has a duration of 4 years and
was awarded through assistance program 93.318 Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security.
The Cooperative Agreement was awarded through grant opportunity Improving Clinical and Public Health Outcomes through National Partnerships to Prevent and Control Emerging and Re-Emerging Infectious Disease Threats.
Status
(Ongoing)
Last Modified 9/5/24
Period of Performance
9/30/21
Start Date
9/29/25
End Date
Funding Split
$5.1M
Federal Obligation
$0.0
Non-Federal Obligation
$5.1M
Total Obligated
Activity Timeline
Transaction History
Modifications to NU50CK000597
Additional Detail
Award ID FAIN
NU50CK000597
SAI Number
NU50CK000597-3883422488
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75CDC1 CDC OFFICE OF FINANCIAL RESOURCES
Funding Office
75CVL0 CDC NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES
Awardee UEI
HA5PL9ZYD188
Awardee CAGE
92320
Performance District
IL-90
Senators
Richard Durbin
Tammy Duckworth
Tammy Duckworth
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
Public Health and Social Services Emergency Fund, Office of the Secretary, Health and Human Services (075-0140) | Health care services | Grants, subsidies, and contributions (41.0) | $2,000,000 | 83% |
Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Health and Human Services (075-0949) | Health care services | Grants, subsidies, and contributions (41.0) | $367,000 | 15% |
Modified: 9/5/24